Fri, Mar 29, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Industry Updates

New Ucits index from Alix Capital

Tuesday, February 22, 2011
Opalesque Industry Update – Alix Capital, the provider of the UCITS Alternative Index announced the launch of a new Index, the UCITS Alternative Index Blue Chip (the “Blue Chip Index”). The objective of the Blue Chip Index is to give a fair, reliable and unbiased representation of the money invested in UCITS hedge funds. The Index is composed of the 50 most representative UCITS hedge funds currently open for investment. The funds included in the Index are selected following transparent, rule based and replicable selection criteria. The Blue Chip Index rules and construction is overseen by a Scientific Committee.

Louis Zanolin, CEO, Alix Capital says: “There has been a huge demand from industry participants such as investment banks, asset managers and consultants for an index that fairly represents the allocation of investor money into the UCITS hedge fund space. After months of research we are pleased to publicly release what we believe will rapidly become the leading UCITS hedge fund Index tracking investor’s monies true allocation.”

Louis Zanolin adds: ”A first investable product linked to the Blue Chip Index has been launched in partnership with our parent company Palaedino Asset Management a few weeks ago. Additional products linked to the Blue Chip Index should soon be offered by third party providers.”Source

Licensing The UCITS Alternative Indices may be licensed by financial institutions including banks, broker dealers, insurance companies and asset managers for the creation of index based financial products such as index funds, insurance products, warrants, structured products and OTC derivatives. A license is required from Alix Capital for any product linked to, or based on, the UCITS Alternative Indices. For further information on licensing the UCITS Alternative Indices, please contact Alix Capital. www.alixcapital.com

(Press release)
bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1